A Phase II Study of the Safety and Efficacy of E7820 Plus Cetuximab in Colorectal Cancer, Preceded by a Run-in Study in Advanced Solid Tumors
Clinical trial NCT00309179 · COMPLETED
Trial details
- NCT number
- NCT00309179
- Sponsor
- Eisai Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-09-24
- Primary completion
- 2009-12-14
- Enrollment
- 41
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.